HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.

Abstract
Insulin-like growth factor binding proteins (IGFBPs) are modulators of numerous cellular processes including cell proliferation. Although IGFBPs classically act by sequestration of extracellular insulin-like growth factors (IGFs), thereby contributing to the fine-tuning of growth factor signals, IGF-independent actions of IGFBPs have also been described. In the breast, growth factor signaling in association with estradiol (E2)-stimulated estrogen receptor function is organized in a complex cross-talk. The importance of phosphatidylinositol 3-kinase/protein kinase B (Akt/PKB) pathway components for the E2-induced activation of estrogen receptor-alpha (ERα) is well accepted. Here we show that in the absence of IGFs, IGFBP-4 or IGFBP-5, either overexpressed in MCF-7 breast cancer cells or added exogenously, decreased the capability of E2 to induce ERα transcriptional activity. In addition, overexpression or addition of recombinant IGFBP-4 or IGFBP-5 resulted in reduction of E2-induced phosphorylation of Akt/PKB, GSK-3α/β and ERα in MCF-7 cells. The activation of the Akt/PKB-pathway describes a non-genomic effect of E2, which did not involve activation/phosphorylation of the IGF-I receptor (IGF-IR). Furthermore, knockdown of the IGF-IR did not affect the inhibition of E2-induced ERα phosphorylation by IGFBP-4 and 5. Moreover, IGFBP-4 and IGFBP-5 strongly decreased E2-triggered growth of MCF-7 cells. Our data suggest that IGFBPs interfere with the E2-induced activation of the Akt/PKB-pathway and prevent full hormone-dependent activation of ERα and breast cancer cell growth in an IGF- and IGF-IR-independent manner.
AuthorsAlexander Hermani, Ashish Shukla, Senad Medunjanin, Haim Werner, Doris Mayer
JournalCellular signalling (Cell Signal) Vol. 25 Issue 6 Pg. 1395-402 (Jun 2013) ISSN: 1873-3913 [Electronic] England
PMID23499909 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier Inc. All rights reserved.
Chemical References
  • Estrogen Receptor alpha
  • Insulin-Like Growth Factor Binding Protein 4
  • Insulin-Like Growth Factor Binding Protein 5
  • RNA, Messenger
  • RNA, Small Interfering
  • Recombinant Proteins
  • Estradiol
  • Insulin-Like Growth Factor I
  • Receptor, IGF Type 1
  • Proto-Oncogene Proteins c-akt
  • Glycogen Synthase Kinase 3
  • glycogen synthase kinase 3 alpha
Topics
  • Breast Neoplasms (metabolism, pathology)
  • Cell Proliferation (drug effects)
  • Estradiol (pharmacology)
  • Estrogen Receptor alpha (genetics, metabolism)
  • Female
  • Glycogen Synthase Kinase 3 (metabolism)
  • Humans
  • Insulin-Like Growth Factor Binding Protein 4 (genetics, metabolism)
  • Insulin-Like Growth Factor Binding Protein 5 (genetics, metabolism)
  • Insulin-Like Growth Factor I (metabolism)
  • MCF-7 Cells
  • Phosphorylation (drug effects)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • RNA Interference
  • RNA, Messenger (metabolism)
  • RNA, Small Interfering (metabolism)
  • Receptor, IGF Type 1 (antagonists & inhibitors, genetics, metabolism)
  • Recombinant Proteins (biosynthesis, genetics, pharmacology)
  • Signal Transduction (drug effects)
  • Transcription, Genetic

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: